Thu, July 31, 2014
Wed, July 30, 2014
Tue, July 29, 2014
Mon, July 28, 2014
Fri, July 25, 2014
Thu, July 24, 2014
Wed, July 23, 2014
Tue, July 22, 2014
Mon, July 21, 2014
Fri, July 18, 2014
Thu, July 17, 2014
Wed, July 16, 2014
Tue, July 15, 2014
Mon, July 14, 2014
Fri, July 11, 2014
Thu, July 10, 2014
Wed, July 9, 2014
Tue, July 8, 2014
Mon, July 7, 2014
Wed, July 2, 2014
Tue, July 1, 2014
Mon, June 30, 2014
Fri, June 27, 2014
Thu, June 26, 2014
Wed, June 25, 2014
Tue, June 24, 2014
Mon, June 23, 2014
Fri, June 20, 2014
Thu, June 19, 2014
Wed, June 18, 2014
Tue, June 17, 2014
Mon, June 16, 2014

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $46 on, Jul 17th, 2014


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-46-on-jul-17th-2014.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $44 to $46 on, Jul 17th, 2014.

Jayson has made no other calls on ABT in the last 4 months.



There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Jayson's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jayson


  • Matt Miksic of "Credit Suisse" Upgraded from Hold to Buy on, Monday, May 19th, 2014

Publication Contributing Sources